Key result
Acute administration of Tempol reduced mean arterial pressure by 35% and increased cortical blood flow by 35% and medullary oxygen tension by 94% in the clipped kidney of chronic 2K,1C rats.
Why the study?
Does acute administration of Tempol, candesartan, or enalaprilat improve mean arterial pressure, renal blood flow, and oxygenation in chronic 2K,1C rats?
Does acute administration of Tempol, candesartan, or enalaprilat improve mean arterial pressure, renal blood flow, and oxygenation in chronic 2K,1C rats?
Answers are grounded in this paper and cite their sources.
In chronic 2K,1C hypertensive rats, acute administration of the ROS inhibitor Tempol is more effective than candesartan in reducing blood pressure and improving renal perfusion and oxygenation.
Angiotensin II maintains renal cortical blood flow and renal oxygenation in the clipped kidney of early 2-kidney, 1-clip Goldblatt hypertensive (2K,1C) rats. The involvement of Ang II is believed to decline, whereas oxidative stress increases during the progression of 2K,1C hypertension. We investigated the hypothesis that the acute administration of drugs to inhibit reactive oxygen species (Tempol), angiotensin II type 1 receptors (candesartan), or angiotensin-converting enzyme (enalaprilat) lowers mean arterial pressure and increases kidney blood flow and oxygenation in the clipped kidney of chronic 2K,1C rats in contrast to sham controls. Twelve months after left renal artery clipping or sham, mean arterial pressure, renal cortical blood flow, and renal cortical and medullary oxygen tension were measured after acute administration of Tempol followed by enalaprilat or candesartan followed by enalaprilat. The mean arterial pressure of the 2K,1C rat was reduced by candesartan (-9%) and, more effectively, by Tempol (-35%). All of the applied treatments had similar blood pressure-lowering effects in sham rats (average: -21%). Only Tempol increased cortical blood flow (+35%) and cortical and medullary oxygen tensions (+17% and +94%, respectively) in clipped kidneys of 2K,1C rats. Administration of enalaprilat had no additional effect, except for a modest reduction in cortical blood flow in the clipped kidney of 2K,1C rats when coadministered with candesartan (-10%). In conclusion, acute administration of Tempol is more effective than candesartan in reducing the mean arterial blood pressure and improving renal blood perfusion and oxygenation in the clipped kidney of chronic 2K,1C rats.
No takes yet. Share an insight, caveat, or question.
Palm et al. (2010) studied Chronic 2-kidney, 1-clip (2K,1C) hypertension. Tempol, candesartan, and enalaprilat vs. Sham controls was evaluated on Mean arterial pressure, renal cortical blood flow, and renal cortical and medullary oxygen tension. Acute administration of Tempol reduced mean arterial pressure by 35% and increased cortical blood flow by 35% and medullary oxygen tension by 94% in the clipped kidney of chronic 2K,1C rats.
Synapse has enriched 10 related papers. Consider them for comparative context: